Suppr超能文献

一例在接受无缝合主动脉生物瓣膜置换术后进行具有挑战性的经皮冠状动脉介入治疗的病例。

A case of challenging percutaneous coronary intervention following surgical aortic valve replacement with a sutureless aortic bioprosthesis.

作者信息

Azumi Yuta, Nakama Tatsuya, Obunai Kotaro, Watanabe Hiroyuki

机构信息

Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.

出版信息

J Cardiol Cases. 2020 Jul 30;22(4):198-201. doi: 10.1016/j.jccase.2020.06.018. eCollection 2020 Oct.

Abstract

A 71-year-old man with symptomatic severe aortic valve stenosis and stenosis of the proximal right coronary artery (RCA) underwent aortic valve replacement with Perceval (LivaNova, London, UK), a sutureless aortic bioprosthesis with a self-expanding open-cell designed nitinol frame (SL-AVR). Seven weeks after the SL-AVR, percutaneous coronary intervention (PCI) to the RCA was required. However, engagement of the guiding catheter (GC) was challenging because the RCA ostium was jailed by the strut of the Perceval. Therefore, the "Mother, Child, and Grandchild Technique" was used. A 4-Fr diagnostic catheter (DC) was partially engaged, and a support type 0.014-inch guidewire (GW) was inserted into the distal RCA. The DC was replaced by a 6-Fr GC. To fill the gap between the 0.014-inch GW and 6-Fr GC, a 5-Fr tapered inner sheath (IS, tip size was 3.0-Fr, used as Child catheter) was inserted into the 6-Fr GC (Mother catheter), and a 2.6-Fr microcatheter (Grandchild catheter) was inserted into the 5-Fr IS. Therefore, the gap between the 0.014-inch GW and 6-Fr GW was obliterated. Finally, we successfully inserted the PCI system and engaged the GC. RCA stenosis was treated using the conventional PCI technique. Herein, we report a case of successful PCI subsequent to SL-AVR. < The technical feasibility of percutaneous coronary intervention (PCI) following aortic valve replacement with a sutureless aortic bioprosthesis with a self-expanding open-cell designed nitinol frame (SL-AVR) remains unclear. In this report, we describe a case of challenging PCI following SL-AVR.>.

摘要

一名71岁男性,患有症状性严重主动脉瓣狭窄及右冠状动脉(RCA)近端狭窄,接受了使用Perceval(英国伦敦LivaNova公司生产)的主动脉瓣置换术,这是一种带有自膨胀开孔设计镍钛诺框架的无缝合主动脉生物假体(SL-AVR)。SL-AVR术后7周,需要对RCA进行经皮冠状动脉介入治疗(PCI)。然而,由于RCA开口被Perceval的支柱卡住,引导导管(GC)的置入具有挑战性。因此,采用了“祖孙三代技术”。将一根4F诊断导管(DC)部分置入,然后将一根支撑型0.014英寸导丝(GW)插入RCA远端。DC被一根6F GC取代。为了填补0.014英寸GW和6F GC之间的间隙,将一根5F锥形内鞘(IS,尖端尺寸为3.0F,用作子导管)插入6F GC(母导管),并将一根2.6F微导管(孙导管)插入5F IS。这样,0.014英寸GW和6F GW之间的间隙就被消除了。最后,我们成功插入了PCI系统并置入了GC。采用传统PCI技术治疗RCA狭窄。在此,我们报告一例SL-AVR术后成功进行PCI的病例。<使用带有自膨胀开孔设计镍钛诺框架的无缝合主动脉生物假体(SL-AVR)进行主动脉瓣置换术后经皮冠状动脉介入治疗(PCI)的技术可行性仍不明确。在本报告中,我们描述了一例SL-AVR术后具有挑战性的PCI病例。>

相似文献

2
7
Aortic valve replacement in patients with protruding coronary artery stents.冠状动脉支架突出患者的主动脉瓣置换术。
J Cardiol Cases. 2014 Aug 22;10(6):213-215. doi: 10.1016/j.jccase.2014.07.013. eCollection 2014 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验